Conditions

Honest, research-backed information about cannabis for specific health conditions — including what the evidence supports, where it falls short, and what we still don't know.

One of the biggest challenges when researching medicinal cannabis is separating what the science actually supports from what marketing and word-of-mouth suggest. At TryCannabis.org, we present the evidence honestly. When research is strong, we say so. When it is mixed, limited, or primarily anecdotal, we say that too.

Every condition page on this site follows the same structure: what the condition is, what the research says (citing actual studies), how people use cannabis for it, practical starting points, risks to be aware of, and how to talk to your doctor. We rate the strength of evidence for each condition so you can calibrate your expectations.

Where Evidence Is Strongest

These conditions have the most robust clinical trial data supporting the use of cannabis or cannabis-derived medications.

Where Evidence Is Mixed But Promising

Research shows real potential for these conditions, but the evidence is nuanced — some studies are positive, others are inconclusive, and dose, potency, and individual factors matter enormously.

Where Evidence Is Limited But Growing

Patient interest is high, and early research is intriguing, but rigorous clinical trials are still lacking for these conditions. Proceed with realistic expectations and medical guidance.

Understanding Our Evidence Ratings

Throughout the conditions section, you will see evidence badges that indicate the strength of the current research. Here is what they mean:

  • Strong EvidenceStrong evidence: Supported by multiple large-scale randomized controlled trials and/or FDA-approved medications. The highest standard of medical evidence.
  • Moderate EvidenceModerate evidence: Supported by some clinical trials and consistent observational data, but large-scale replication is still needed.
  • Mixed EvidenceMixed evidence: Some studies show benefit while others do not. Results may depend heavily on dose, product type, or individual factors.
  • Limited EvidenceLimited evidence: Primarily preclinical (lab/animal studies), anecdotal, or based on small observational studies. Promising but unproven in rigorous human trials.

These ratings reflect our honest assessment of the current state of research. They will be updated as new evidence becomes available. For more on why cannabis research has been limited historically, visit our Evidence Gap page.

Important: An evidence rating of "limited" does not mean cannabis definitely doesn't help for that condition. It means we don't have enough high-quality research to say for sure. The federal classification of cannabis as a Schedule I substance has historically made rigorous research extraordinarily difficult to conduct. The evidence base is growing rapidly, with over 4,000 scientific papers published on cannabis in 2025 alone.